Resmed Inc (RMD) - Comprehensive Stock Analysis & Investment Research
Deep dive into Resmed Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Resmed Inc Investment Summary
When evaluating whether Resmed Inc (RMD) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Resmed Inc (RMD) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. The company employs approximately 5,138 people. With a market capitalization of $37 billion, the company is a large-cap stock offering relative stability combined with growth potential.
Financial Performance Analysis
Our comprehensive financial analysis covers Resmed Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Resmed Inc along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Resmed Inc is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Resmed Inc (Stock Symbol: RMD) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Resmed Inc's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Resmed Inc...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Resmed Inc...
Revenue & Growth Analysis
Resmed Inc generates annual revenues of $5 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Resmed Inc...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Resmed Inc...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Resmed Inc...
Strategic Market Position
Resmed Inc strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.
Industry Competitive Landscape
Resmed Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company shows positive operational efficiency through free cash flow generation of $344 million annually , with year-over-year cash flow growth of -8.2%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.
Margin & Pricing Power Analysis
The company maintains a 61.7% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of 23.5% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This strong operating margin indicates excellent cost control and efficient organizational structure relative to the revenue base.
Asset Utilization Efficiency
Asset turnover ratio of 0.75x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.
Financial Strength & Leverage
Current ratio of 2.55 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.